Keyword: Proteus Digital Health
Otsuka and Proteus re-upped their smart-tablet partnership for another five years, aiming to develop a new generation of ingestible sensors.
The approval clears Otsuka to start selling a sensor-enabled version of its schizophrenia drug Abilify designed to improve compliance.
CFO Jeff Poulton will leave Shire, Novartis hired a retail expert as chief digital officer, and ex-Zealand chief David Horn Solomon will lead troubled Akari.
Otsuka and Proteus Digital Health have refiled for FDA approval of their digital medicine, hoping to address shortcomings that spurred a previous FDA rejection.